(PharmaNewsWire.Com, October 02, 2017 ) Clostridium bacteria are widely found in soil and the guts of various animals. These microbes are anaerobic in nature and produce a wide range of toxins leading to various diseases in animals. Some of these diseases are zoonotic in nature. Vaccines play a major role in protecting the animals against all the Clostridia diseases. Various types of vaccines are available, either in a single form or in combinations, which consist of bacterins, toxoids, or mixtures of bacterins and toxoids.
Publisher's analysts forecast the global veterinary clostridium vaccine market to grow at a CAGR of 4.96% during the period 2017-2021. For more information about this report: http://www.reportsweb.com/global-veterinary-clostridium-vaccine-market-2017-2021 . Covered in this report The report covers the present scenario and the growth prospects of the global veterinary clostridium vaccine market for 2017-2021. To calculate the market size, the report considers sales of Clostridium vaccines.
The market is divided into the following segments based on geography: - Americas - APAC - EMEA
Publisher's report, Global Veterinary Clostridium Vaccine Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors - Elanco - Merck - Merial (now part of Boehringer Ingelheim) - Zoetis
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: